Anne Milgram

The Drug Enforcement Administration (DEA) will hold its first hearing on December 2 to address the Biden administration’s proposal to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA). The hearing, announced through a public advisory on November 26...

The Drug Enforcement Administration (DEA) has denied accusations of improper communication with cannabis prohibitionist group Smart Approaches to Marijuana (SAM) during the Biden administration's marijuana rescheduling process. In a recent filing reported by Marijuana Moment, the agency dismissed...

For the first time in years, the U.S. is witnessing a sustained decline in overdose deaths. Federal data reveals a 14.5% drop in fatalities over 12 months ending June 2024, marking a significant shift after years of grim records. Experts attribute the change to a combination of expanded harm...

A Washington-based researcher has filed a lawsuit against the Drug Enforcement Administration (DEA), alleging multiple legal violations in the agency's process of rescheduling marijuana. As Forbes reported, the complaint, filed in the U.S. District Court for Western Washington, names the Department...

The death of “Friends” actor Matthew Perry has spurred the Drug Enforcement Administration (DEA) into action. The agency is drawing alarming parallels between the rise in ketamine use and the early days of the opioid epidemic. As Double Blind reported, the DEA is now signaling a...

Congressman Earl Blumenauer, a Democrat from Oregon and co-chair of the Congressional Cannabis Caucus says he’s disappointed the U.S. Drug Enforcement Administration (DEA) chose to delay rescheduling of marijuana. "It is incredibly disappointing to see the DEA drag their feet on an issue...

In a move that could significantly impact the cannabis reform landscape, the Drug Enforcement Administration (DEA) announced a delay on Monday in the rescheduling of marijuana, noting it would hold an administrative hearing for December 2, which pushes any decision on the matter until after the...

A group of the U.S. senators are yet again pushing Attorney General Merrick Garland and DEA administrator Anne Milgram to reschedule marijuana. Senators Reiterate Support For Marijuana Reclassification In a letter made public on Friday, the senators expressed their support for the DEA's proposal...

The cannabis market saw a surge that waned by Friday, with the AdvisorShares Pure US Cannabis ETF (NYSE:MSOS) falling by 2.50% over the week, and the Global X Cannabis ETF (NYSE:YOLO) dropping 1.73%. Ascend's Financial Restructuring One notable bright spot was Ascend Wellness Holdings (OTC:AAWH),...

Kentucky Governor Andy Beshear is urging the Drug Enforcement Administration (DEA) to ease restrictions on marijuana. In a recent letter addressed to DEA administrator Anne Milgram, Beshear advocated for the reclassification of cannabis from a Schedule I drug, which includes substances like heroin...

The Supreme Court recently ruled in a case Jarkesy versus Securities and Exchange Commission (SEC) that defendants have a right to a jury trial under the Seventh Amendment when facing enforcement actions from federal agencies, writes Vox. While this case considered a hedge fund manager accused of...

Congressional members Rep. Andrew Clyde (R-GA) and Rep. Ben Cline (R-VA) are demanding answers from DEA administrator Anne Milgram about why she did not sign the recent White House proposal to reschedule cannabis rather than having it approved by Attorney General Merrick Garland, thus breaking with...

Following President Joe Biden's recent announcement regarding the rescheduling of cannabis followed by Attorney General Merrick Garland's move to officially begin the process, many expected the task to then be delegated to the DEA, which is part of the Dept. of Justice (DOJ). That didn’t...

Last Tuesday's breaking news of cannabis rescheduling drove the cannabis industry into overdrive with elated thoughts from tax relief to soaring marijuana stocks to cannabis scientists presuming they no longer have to keep their research labs locked up like Fort Knox. And now…the air seems to be...

Canadian Prime Minister Justin Trudeau said there were no downsides to cannabis legalization in a recent interview with France TV. "The only downside we were extremely worried about was that it would place us in non-compliance with certain international treaties on drug control," Trudeau said. "We...